Since its inception, CRF has brought together the efforts of preeminent physicians and researchers from a variety of cardiologic disciplines, while disseminating their ideas in educational forums that transcend institutional and national borders. CRF has effectively combined frontline research with global education in order to significantly raise the quality of cardiovascular patient care.
CRF has also played a leadership role in initiating and enhancing the progress of device and drug development, through extensive clinical trials involving stents and stent-grafts, radiation, gene and protein-based therapies, stem cell implantation, new imaging methods, drug-eluting stents, and more.
All of these activities are made possible with the support of foundation grants, corporate funding, and the generosity of private donations. Additional support will allow CRF to continue developing seminal programs and initiatives such as these, and to meet future challenges in interventional vascular medicine.
If you would like to support CRF's work, please use the form below to make a contribution.
CRF is a 501(c)3 non-profit organization.
Opportunities to Contribute
- A tribute gift recognizes a special occasion for a family member, friend or colleague. We will send an acknowledgement to the person you specify announcing the gift but not the amount.
- A memorial gift honors an individual who has passed away. We will send an acknowledgement to surviving family or friends without specifying the amount.
- A group gift from your school or organization will be acknowledged with a special certificate created especially for your class or special event.
- Your bequest can help sustain the vision of CRF. Please call for details on how to remember CRF in your estate planning.
If you are considering a gift of $1,000 or more, you may realize substantial tax savings by giving appreciated securities. For more information, please contact Irma Damhuis at 646-434-4690 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
